GSK Jan 2024 38.000 call
| Previous close | 7.6100 |
| Open | 3.4200 |
| Bid | 3.3000 |
| Ask | 3.9000 |
| Strike | 38.00 |
| Expiry date | 2024-01-19 |
| Day's range | 3.2000 - 3.4200 |
| Contract range | N/A |
| Volume | |
| Open interest | 64 |
- Bloomberg
Deutsche Bank, UBS in Focus as Wall Street Sends Mixed Signals
(Bloomberg) -- Mixed results from Wall Street earlier in January raise the ante on European lenders limbering up to report earnings next week, a week in which the European Central Bank’s Governing Council also meets to set policy for the first time in 2023.Most Read from BloombergHindenburg vs Adani: The Short Seller Taking On Asia’s Richest PersonWe Asked ChatGPT to Make a Market-Beating ETF. Here’s What HappenedNYSE Mayhem Traced to a Staffer Who Left a Backup System RunningAdani Rout Crosses
- Zacks
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Yahoo Finance UK
Wall Street flat as earnings roll while FTSE closes in red
UK public borrowing increased by more than expected last month as the government ploughed billions into its subsidies for household bills.
